FOURTH-QUARTER 2024 EARNINGS Baxter International Inc. February 20, 2025 1 FORWARD-LOOKING STATEMENTS This presentation includes forward-looking statements concerning the company's financial results (including the outlook for first-quarter and full-year 2025) and business development and regulatory activities. These forward-looking statements are based on assumptions about many important factors, including the following, which could cause actual results to differ materially from those in the forward-looking ...

Baxter International Inc. (BAX) reported fourth-quarter 2024 adjusted earnings per share (EPS) of 58 cents, which beat the Zacks Consensus Estimate of 52 cents by 11.5%. The bottom line declined 10.8% from the year-ago quarter’s level due to a surge in costs and expenses.On a GAAP basis, the company reported a loss per share of 95 cents against EPS of 43 cents in the prior-year quarter. The significant loss was due to special items, primarily related to the impact of a Front Line Care goodwill impairment ch ...

Baxter International Inc. (NYSE:BAX) Q4 2024 Earnings Conference Call February 20, 2025 8:30 AM ET Company Participants Clare Trachtman - SVP and Chief IRO Brent Shafer - Chairman, and Interim CEO Heather Knight - COO Joel Grade - EVP and CFO Conference Call Participants Robert Marcus - JPMorgan David Roman - Goldman Sachs Matt Miksic - Barclays Vijay Kumar - Evercore ISI Travis Steed - Bank of America Securities Lawrence Biegelsen - Wells Fargo Danielle Antalffy - UBS Operator Good morning, ladies and gent ...

Baxter International (BAX) reported $2.75 billion in revenue for the quarter ended December 2024, representing a year-over-year decline of 29.1%. EPS of $0.58 for the same period compares to $0.88 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $2.66 billion, representing a surprise of +3.49%. The company delivered an EPS surprise of +11.54%, with the consensus EPS estimate being $0.52.While investors scrutinize revenue and earnings changes year-over-year and how they compare wit ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 1, 2025 Baxter International Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) (Commission File Number) 1-4448 36-0781620 (I.R.S. Employer Identification No.) One Baxter Parkway, Deerfield, Illinois 60015 (Address of pri ...

Baxter International Inc. (BAX) is scheduled to release fourth-quarter 2024 results on Feb. 13, before the opening bell. In the last reported quarter, the company’s earnings beat the Zacks Consensus Estimate by 2.56%. BAX’s earnings beat estimates in each of the trailing four quarters, delivering an average surprise of 3.62%.Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar.Q4 EstimatesCurrently, the consensus estimate for revenues is pegged at $2.66 billion, indicating a decline of 3 ...

In its upcoming report, Baxter International (BAX) is predicted by Wall Street analysts to post quarterly earnings of $0.52 per share, reflecting a decline of 40.9% compared to the same period last year. Revenues are forecasted to be $2.66 billion, representing a year-over-year decrease of 31.5%.Over the last 30 days, there has been no revision in the consensus EPS estimate for the quarter. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this ti ...

Vantive builds on a 70-year legacy of kidney care leadership and innovation, with a singular focus on empowering patients and care teams with more flexible, collaborative and accessible care options With over 1 million daily interactions with patients across more than 100 countries, Vantive exists to extend lives and expand possibilities for patients everywhere DEERFIELD, Ill., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Vantive, formerly the Baxter Kidney Care segment, today launched as a new standalone vital organ ...

In the world of equities, not all stocks shine brightly in the heavens. Some inevitably find themselves in the shadows, struggling against the tides of market sentiment. Such is the case with today’s Bear of the Day, a stock currently enshrouded in bearish clouds, casting doubt on its future trajectory.I’m talking about Zacks Rank #5 (Strong Sell) Baxter ((BAX) ).Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates thro ...

Baxter International (BAX) recently announced the launch of five new injectable pharmaceutical products in the United States, which, when combined with the previous five launches announced in April 2024, marks a total of 10 U.S. injectable product launches in 2024.These new launches reinforce Baxter’s leadership in bringing high-value, specialty injectable products to market to help address critical patient needs. The launches further strengthen Baxter’s Pharamaceutical business segment.Likely Trend of BAX ...